379 related articles for article (PubMed ID: 19283066)
21. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.
Niedobitek G; Agathanggelou A; Rowe M; Jones EL; Jones DB; Turyaguma P; Oryema J; Wright DH; Young LS
Blood; 1995 Jul; 86(2):659-65. PubMed ID: 7605996
[TBL] [Abstract][Full Text] [Related]
22. EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins.
Fitzsimmons L; Cartlidge R; Chang C; Sejic N; Galbraith LCA; Suraweera CD; Croom-Carter D; Dewson G; Tierney RJ; Bell AI; Shannon-Lowe C; Herold MJ; Rickinson AB; Colman PM; Huang DCS; Strasser A; Kvansakul M; Rowe M; Kelly GL
Cell Death Differ; 2020 May; 27(5):1554-1568. PubMed ID: 31645677
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.
Tierney RJ; Steven N; Young LS; Rickinson AB
J Virol; 1994 Nov; 68(11):7374-85. PubMed ID: 7933121
[TBL] [Abstract][Full Text] [Related]
24. BHRF1, the Epstein-Barr virus (EBV) homologue of the BCL-2 protooncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocytes.
Oudejans JJ; van den Brule AJ; Jiwa NM; de Bruin PC; Ossenkoppele GJ; van der Valk P; Walboomers JM; Meijer CJ
Blood; 1995 Sep; 86(5):1893-902. PubMed ID: 7655018
[TBL] [Abstract][Full Text] [Related]
25. Epstein-barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma.
Ruf IK; Rhyne PW; Yang H; Borza CM; Hutt-Fletcher LM; Cleveland JL; Sample JT
Mol Cell Biol; 1999 Mar; 19(3):1651-60. PubMed ID: 10022853
[TBL] [Abstract][Full Text] [Related]
26. Dominant-negative derivative of EBNA1 represses EBNA1-mediated transforming gene expression during the acute phase of Epstein-Barr virus infection independent of rapid loss of viral genome.
Kariya Y; Hamatake M; Urano E; Yoshiyama H; Shimizu N; Komano J
Cancer Sci; 2010 Apr; 101(4):876-81. PubMed ID: 20132216
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus nuclear antigen 3A promotes cellular proliferation by repression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1.
Tursiella ML; Bowman ER; Wanzeck KC; Throm RE; Liao J; Zhu J; Sample CE
PLoS Pathog; 2014 Oct; 10(10):e1004415. PubMed ID: 25275486
[TBL] [Abstract][Full Text] [Related]
28. EBV and Apoptosis: The Viral Master Regulator of Cell Fate?
Fitzsimmons L; Kelly GL
Viruses; 2017 Nov; 9(11):. PubMed ID: 29137176
[TBL] [Abstract][Full Text] [Related]
29. A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus.
Feederle R; Linnstaedt SD; Bannert H; Lips H; Bencun M; Cullen BR; Delecluse HJ
PLoS Pathog; 2011 Feb; 7(2):e1001294. PubMed ID: 21379335
[TBL] [Abstract][Full Text] [Related]
30. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
31. Epstein-barr virus-induced resistance to drugs that activate the mitotic spindle assembly checkpoint in Burkitt's lymphoma cells.
Leao M; Anderton E; Wade M; Meekings K; Allday MJ
J Virol; 2007 Jan; 81(1):248-60. PubMed ID: 17035311
[TBL] [Abstract][Full Text] [Related]
32. Structural basis for apoptosis inhibition by Epstein-Barr virus BHRF1.
Kvansakul M; Wei AH; Fletcher JI; Willis SN; Chen L; Roberts AW; Huang DC; Colman PM
PLoS Pathog; 2010 Dec; 6(12):e1001236. PubMed ID: 21203485
[TBL] [Abstract][Full Text] [Related]
33. Unexpected patterns of Epstein-Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA.
Tierney RJ; Shannon-Lowe CD; Fitzsimmons L; Bell AI; Rowe M
Virology; 2015 Jan; 474():117-30. PubMed ID: 25463610
[TBL] [Abstract][Full Text] [Related]
34. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
[TBL] [Abstract][Full Text] [Related]
35. trans-Repression of protein expression dependent on the Epstein-Barr virus promoter Wp during latency.
Hughes DJ; Dickerson CA; Shaner MS; Sample CE; Sample JT
J Virol; 2011 Nov; 85(21):11435-47. PubMed ID: 21865378
[TBL] [Abstract][Full Text] [Related]
36. Hairy leukoplakia: an unusual combination of transforming and permissive Epstein-Barr virus infections.
Webster-Cyriaque J; Middeldorp J; Raab-Traub N
J Virol; 2000 Aug; 74(16):7610-8. PubMed ID: 10906215
[TBL] [Abstract][Full Text] [Related]
37. Repression of the proapoptotic cellular BIK/NBK gene by Epstein-Barr virus antagonizes transforming growth factor β1-induced B-cell apoptosis.
Campion EM; Hakimjavadi R; Loughran ST; Phelan S; Smith SM; D'Souza BN; Tierney RJ; Bell AI; Cahill PA; Walls D
J Virol; 2014 May; 88(9):5001-13. PubMed ID: 24554662
[TBL] [Abstract][Full Text] [Related]
38. Unique Epstein-Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection.
Yoshioka M; Kikuta H; Ishiguro N; Ma X; Kobayashi K
J Gen Virol; 2003 May; 84(Pt 5):1133-1140. PubMed ID: 12692278
[TBL] [Abstract][Full Text] [Related]
39. c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.
Faumont N; Durand-Panteix S; Schlee M; Grömminger S; Schuhmacher M; Hölzel M; Laux G; Mailhammer R; Rosenwald A; Staudt LM; Bornkamm GW; Feuillard J
J Virol; 2009 May; 83(10):5014-27. PubMed ID: 19264782
[TBL] [Abstract][Full Text] [Related]
40. Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation.
Amoroso R; Fitzsimmons L; Thomas WA; Kelly GL; Rowe M; Bell AI
J Virol; 2011 Jan; 85(2):996-1010. PubMed ID: 21068248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
